Wall Street expects a year-over-year increase in earnings on higher revenues when Inogen (INGN) reports results for the quarter ended December 2025. While this widely-known consensus outlook is ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters due to high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid third-quarter 2025 performance and ...

Home respiratory is a cornerstone of the HME industry, but manufacturers and providers are redefining what success in the market looks like: Oxygen therapy that keeps pace with patients, durable ...

Inogen, Inc. INGN recently announced the launch of its Inogen One G5 portable oxygen concentrator. The product is now available for sale through the company’s domestic direct-to-consumer sales channel ...

Engineered for superior comfort, reliability, and usability, Aurora Masks establishes Inogen’s presence in the growing sleep-therapy market and expands Inogen’s addressable market opportunity. The ...

Inogen Inc (NASDAQ:INGN), a medical technology company, reported fourth-quarter 2023 revenues of $75.90 million, missing the consensus of $76.99 million. Fourth quarter total revenue fell from $88.1 ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that its Board of ...

Sandra Gordon is a journalist specializing in health and medicine for consumers and healthcare providers. Her work has appeared in major magazines and websites, including Prevention, Parents, Medical ...